• Users Online: 4037
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 31  |  Issue : 4  |  Page : 733-740

Study of proinflammatory and anti-inflammatory states in myelodysplastic syndrome patients

1 Department of Internal Medicine, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt
2 Department of Community, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt
3 Department of Clinical Pathology, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt

Correspondence Address:
Alaa E Hassan
Sabry Abu Alam Street, 32513 Shebin El-Kom, Menoufia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ejim.ejim_37_19

Rights and Permissions

Background The myelodysplastic syndrome (MDS) are a group of clonal bone marrow neoplasms characterized by ineffective hematopoiesis, manifested by morphologic dysplasia in hematopoietic cells and by peripheral cytopenia(s) although previous studies have shown cytogenetic and molecular abnormalities, the underlying defect in the molecular pathway for inflammation milieu, extensive apoptosis, and dysplasia observed in the disease is yet to be studied. Aim of the work The aim of this study was to show the proinflammatory [tumor necrosis factor-α (TNF-α)/anti-inflammatory [interleukin-10 (IL-10)] balance in different subclassifications of MDS. Patients and methods From September 2017 through September 2018, serum levels were measured in 49 patients for TNF-α, IL-10 in patients diagnosed as having MDS. Also, these inflammatory cytokines had been measured in 46 apparently healthy participants as matched controls for the study. The diagnosis of MDS was confirmed by a hematopathologist after review of bone marrow aspiration and/or peripheral blood samples. Conventional cytogenetic studies were performed on bone marrow aspirate material using standard G-banding techniques. These patients were then subclassified according to the revised 2016 WHO classification for MDS. Results There is a statically significant difference between MDS patients and control group according to the results of serum level of TNF-α and IL-10. They were higher in MDS patients. Also, there was a statically significant difference between the subclassified groups of MDS patients according the results of serum level of TNF-α and IL-10. TNF-α was higher in MDS with multilineage dysplasia and MDS unclassifiable than the others. Also, IL-10 was higher in MDS with excess blasts 1 and MDS with excess blasts 2 than the others. Conclusion TNF-α and IL-10 are increased in MDS patients indicating an inflammatory disturbance. TNF-α and IL-10 serum level are inversely related to each other in the different subclasses of MDS.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded14    
    Comments [Add]    

Recommend this journal